GB0721419D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0721419D0 GB0721419D0 GBGB0721419.0A GB0721419A GB0721419D0 GB 0721419 D0 GB0721419 D0 GB 0721419D0 GB 0721419 A GB0721419 A GB 0721419A GB 0721419 D0 GB0721419 D0 GB 0721419D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0721419.0A GB0721419D0 (en) | 2007-10-31 | 2007-10-31 | Compounds |
PCT/EP2008/064635 WO2009056556A1 (en) | 2007-10-31 | 2008-10-29 | Substitute 1, 6-naphthyridines for use as scd inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0721419.0A GB0721419D0 (en) | 2007-10-31 | 2007-10-31 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0721419D0 true GB0721419D0 (en) | 2007-12-12 |
Family
ID=38834636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0721419.0A Ceased GB0721419D0 (en) | 2007-10-31 | 2007-10-31 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0721419D0 (en) |
WO (1) | WO2009056556A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0722075D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
GB0722077D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
RU2014119426A (en) | 2011-10-15 | 2015-11-20 | Дженентек, Инк. | WAYS OF APPLICATION OF SCD1 ANTAGONISTS |
CN104788450A (en) * | 2015-04-23 | 2015-07-22 | 湖南华腾制药有限公司 | Method for preparing pyridino-piperazine derivative |
CN106478435A (en) * | 2016-08-30 | 2017-03-08 | 枣阳市福星化工有限公司 | A kind of method of production 2 methylamino, 5 chlorobenzophenone |
CN106478434A (en) * | 2016-08-30 | 2017-03-08 | 枣阳市福星化工有限公司 | A kind of method of production 2 methylamino, 5 chlorobenzophenone |
CN106496050A (en) * | 2016-08-30 | 2017-03-15 | 枣阳市福星化工有限公司 | A kind of method of production 2 amino, 5 chlorobenzophenone |
CN106366007A (en) * | 2016-08-30 | 2017-02-01 | 枣阳市福星化工有限公司 | Method for producing 2-amino-5-chlorobenzophenone |
US11970486B2 (en) | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
US20200268728A1 (en) | 2016-12-20 | 2020-08-27 | Sumitomo Dainippon Pharma Co., Ltd. | Drug targeting cancer stem cell |
BR112019013954A2 (en) | 2017-01-06 | 2020-02-11 | Yumanity Therapeutics, Inc. | METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
EP3700934A4 (en) | 2017-10-24 | 2021-10-27 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
WO2019183587A1 (en) * | 2018-03-23 | 2019-09-26 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
WO2023231964A1 (en) * | 2022-05-30 | 2023-12-07 | 赛诺哈勃药业(成都)有限公司 | Use of tetrahydronaphthyridine derivative for preparation of medicine for preventing and treating adhesion-related diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007050124A1 (en) * | 2005-05-19 | 2007-05-03 | Xenon Pharmaceuticals Inc. | Fused piperidine derivatives and their uses as therapeutic agents |
-
2007
- 2007-10-31 GB GBGB0721419.0A patent/GB0721419D0/en not_active Ceased
-
2008
- 2008-10-29 WO PCT/EP2008/064635 patent/WO2009056556A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009056556A1 (en) | 2009-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0706793D0 (en) | Compounds | |
GB0704407D0 (en) | Compounds | |
GB0704394D0 (en) | Compounds | |
GB0721419D0 (en) | Compounds | |
GB0705672D0 (en) | Compounds | |
GB0706173D0 (en) | Compounds | |
GB0707092D0 (en) | Compounds | |
GB0706165D0 (en) | Compounds | |
GB0706168D0 (en) | Compounds | |
GB0706188D0 (en) | Compounds | |
GB0707034D0 (en) | Compounds | |
GB0706189D0 (en) | Compounds | |
GB0706174D0 (en) | Compounds | |
GB0706187D0 (en) | Compounds | |
GB0706167D0 (en) | Compounds | |
GB0706170D0 (en) | Compounds | |
GB0706190D0 (en) | Compounds | |
GB0706164D0 (en) | Compounds | |
GB0704939D0 (en) | Compounds | |
GB0703756D0 (en) | Compounds | |
GB0701955D0 (en) | Compounds | |
GB0701985D0 (en) | Compounds | |
GB0706176D0 (en) | Compounds | |
GB0701969D0 (en) | Compounds | |
GB0702863D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |